DexCom plans to launch its 15-day G7 sensor in the second half of 2025, pending FDA approval. A longer wear time may boost ...

THE new evidence put forward by Lucy Letby’s defence lawyers is “full of errors”, according to the families of the babies she ...

Amsterdam played host to this year's edition of the International Conference on Advanced Technologies & Treatments for ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published.

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

More than 38 million people in the US have been diagnosed with diabetes, and about 8.4 million Americans rely on insulin therapy. "For the millions of people who rely on daily injections of ...

CINCINNATI, March 25, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable ... Union Medical Device Regulation (EU MDR) CE Mark approval of the enFuse Syringe Transfer System.

Enable Injections’ enFuse Syringe Transfer System has secured CE mark approval under the European Union Medical Device Regulation (EU MDR). This approval allows the company to distribute drug ...

(MENAFN- GlobeNewsWire - Nasdaq) CINCINNATI, March 25, 2025 (GLOBE NEWSWIRE) -- Enable Injections ... Union Medical Device Regulation (EU MDR) CE Mark approval of the enFuse Syringe Transfer ...